Stay updated on Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page’s system/version footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3”.
    Difference
    0.1%
    Check dated 2026-04-26T15:30:20.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T13:45:29.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Page revision label updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-21T18:38:49.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page, indicating a minor document update.
    Difference
    0.1%
    Check dated 2026-03-07T04:47:42.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2; no substantive study content, endpoints, or locations were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T13:33:59.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Revision label changed from v3.4.0 to v3.4.1 with no impact on content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T09:15:22.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Salivary Gland Cancer Clinical Trial page.